Share this article

 Email

 Print

 

Republish this article

The text of this article by Futurity is licensed under a Creative Commons Attribution-No Derivatives License.

More
Health & Medicine

Diabetes rises sharply among UK’s young adults

Peptides kick-start body to fight sepsis

Depressed people’s body clocks ‘out of sync’

Nose swabs confirm H1N1 flu in seals

Self-destructive nerves can be beneficial

Chats with mom may keep students healthy

Genetic ‘typos’ linked to testicular cancer

Wireless helmet detects brain bleeding

Tripped T-cells reject transplant organs

The study, published in the journal, Journal of Consulting and Clinical Psychology, found no such relationship when it came to thwarting alcohol abuse.

Only 10 percent of 192 adolescents whose depression receded after 12 weeks of treatment later abused drugs, compared to 25 percent of those for whom treatment did not work, says John Curry, a professor of psychology and neuroscience at Duke University who led the study.

“It turned out that whatever they responded to—cognitive behavioral therapy, Prozac, both treatments, or a placebo—if  they did respond within 12 weeks they were less likely to develop a drug-use disorder.”

Researchers followed nearly half the 439 participants from the “Treatment for Adolescents with Depression Study” (TADS; 2000-2003), led by John March, chief of Child and Adolescent Psychiatry at Duke University Medical Center. TADS is considered the largest sample of adolescents who had been treated for major depression.

Participants were ages 17-23 at the end of the five-year follow-up study and had no preexisting problems with abusing alcohol or drugs.

Marijuana was the most prevalent drug used by study participants (76 percent); other drugs included cocaine, opiates, and hallucinogens. Adolescents must have had at least five symptoms for a length of time to be diagnosed with major depression prior to treatment: depressed mood; loss of interest; disruptions in appetite, sleep, or energy; poor concentration; worthlessness; and suicidal thoughts or behavior.

Improved mood regulation due to medicine or skills learned in cognitive-behavior therapy, along with support and education that came with all of the treatments, may have played key roles in keeping the youths off drugs.

The researchers were surprised to find no differences in alcohol abuse and do not have an answer for why. Curry thinks the prevalence of alcohol use among people ages 17-23 may be a key factor.

“It does point out that alcohol use disorders are very prevalent during that particular age period and there’s a need for a lot of prevention and education for college students to avoid getting into heavy drinking and then the beginnings of an alcohol disorder,” Curry says. “I think that is definitely a take-home message.”

Alcohol abuse also led to repeat bouts with depression for some participants.

“When the teenagers got over the depression, about half of them stayed well for the whole five-year period, but almost half of them had a second episode of depression,” Curry says. “And what we found out was that, for those who had both alcohol disorder and another depression, the alcohol disorder almost always came first.”

Curry and co-author Susan Silva, associate professor and statistician in the Duke School of Nursing, believe more study is needed because the number of participants who developed drug or alcohol disorders was relatively small.

Also, there was no comparison group of non-depressed patients, so the researchers could not be sure that rates of subsequent drug and alcohol abuse disorders were higher than those for adolescents not treated for depression.

More news from Duke University: http://today.duke.edu/